In recent years, the role of ENTPD3 in glucose homeostasis and cancer progression has also been preliminarily explored, identifying it as a marker for human mature pancreatic β-cells and a tumor suppressor in breast cancer [70,71,72]. Here, ENTPD3 is linked to breast cancer.